These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33575202)

  • 1. SYNTHESIS AND EVALUATION OF WATER-SOLUBLE DIMETHYLAMINOETHYL ETHERS OF METHOXSALEN FOR PROLIFERATIVE SKIN DISORDERS.
    Guillon CD; Jan YH; Foster N; Choudhuri M; Saxena J; Mariano TM; Heck DE; Laskin JD; Heindel ND
    Heterocycl Lett; 2018; 8(4):729-736. PubMed ID: 33575202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a Pyranocoumarin Photosensitizer that is a Potent Inhibitor of Keratinocyte Growth.
    Laskin JD; Jan YH; Jetter MM; Guillon CD; Mariano TM; Heck DE; Heindel ND
    Photochem Photobiol; 2018 May; 94(3):577-582. PubMed ID: 29315592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-impermeant pyridinium derivatives of psoralens as inhibitors of keratinocyte growth.
    Mariano TM; Vetrano AM; Gentile SL; Heck DE; Whittemore MS; Guillon CD; Jabin I; Rapp RD; Heindel ND; Laskin JD
    Biochem Pharmacol; 2002 Jan; 63(1):31-9. PubMed ID: 11754871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of growth inhibition in keratinocytes by mercurio-substituted 4',5'-dihydropsoralens.
    Martey CA; Vetrano AM; Whittemore MS; Mariano TM; Gentile SL; Heck DE; Laskin DL; Heindel ND; Laskin JD
    Biochem Pharmacol; 2002 Jun; 63(11):2001-9. PubMed ID: 12093477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralens percutaneous permeation across the human whole skin and the epidermis in respect to their polarity (in vitro study).
    Saïd A; Makki S; Muret P; Humbert P; Millet J
    J Dermatol Sci; 1997 Feb; 14(2):136-44. PubMed ID: 9039977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bath-water PUVA therapy with 8-methoxypsoralen in mycosis fungoides.
    Weber F; Schmuth M; Sepp N; Fritsch P
    Acta Derm Venereol; 2005; 85(4):329-32. PubMed ID: 16191854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA.
    Grass JA; Hei DJ; Metchette K; Cimino GD; Wiesehahn GP; Corash L; Lin L
    Blood; 1998 Mar; 91(6):2180-8. PubMed ID: 9490707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Methoxy psoralen, etretinate, and UVA for psoriasis.
    Lane-Brown M
    Int J Dermatol; 1987 Dec; 26(10):655-9. PubMed ID: 3429102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 8-methoxypsoralen and ultraviolet light A on EGF receptor (HER-1) expression.
    Yang XY; Ronai ZA; Santella RM; Weinstein IB
    Biochem Biophys Res Commun; 1988 Dec; 157(2):590-6. PubMed ID: 2462418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 CYP1B1 interacts with 8-methoxypsoralen (8-MOP) and influences psoralen-ultraviolet A (PUVA) sensitivity.
    Deeni YY; Ibbotson SH; Woods JA; Wolf CR; Smith G
    PLoS One; 2013; 8(9):e75494. PubMed ID: 24086543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phototherapy and photopharmacology.
    Gasparro FP; Chan G; Edelson RL
    Yale J Biol Med; 1985; 58(6):519-34. PubMed ID: 3832664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoralen binding and inhibition of epidermal growth factor binding by psoralen/ultraviolet light (PUVA) in human epithelial cells.
    Laskin JD; Lee E
    Biochem Pharmacol; 1991 Jan; 41(1):125-32. PubMed ID: 1846071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of psoralen plus ultraviolet A radiation on in vivo growth of melanoma cells.
    Aubin F; Donawho CK; Kripke ML
    Cancer Res; 1991 Nov; 51(21):5893-7. PubMed ID: 1933857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of action of psoralens: isobologram analysis reveals that ultraviolet light potentiation of psoralen action is not additive but synergistic.
    Yurkow EJ; Laskin JD
    Cancer Chemother Pharmacol; 1991; 27(4):315-9. PubMed ID: 1998988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of photochemotherapy with psoralens and UVA (PUVA): 2000 BC to 1992 AD.
    Pathak MA; Fitzpatrick TB
    J Photochem Photobiol B; 1992 Jun; 14(1-2):3-22. PubMed ID: 1432383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of time-dependent response to psoralen plus UVA (PUVA) treatment with topical 8-methoxypsoralen (8-MOP) gel in palmoplantar dermatoses.
    Engin B; Oguz O
    Int J Dermatol; 2005 Apr; 44(4):337-9. PubMed ID: 15811091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-Alkyl- and 3-aryl-7H-furo[3,2-g]-1-benzopyran-7-ones: synthesis, photoreactivity, and fluorescence properties.
    Körner P
    Arch Pharm (Weinheim); 2002 May; 335(5):187-99. PubMed ID: 12210775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.